The Effect of Abdominal Binders on Patient's Wellbeing After Cesarean Delivery

NCT ID: NCT06564064

Last Updated: 2024-08-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-07-15

Study Completion Date

2024-10-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The effect of abdominal binders on patient's wellbeing after cesarean delivery

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The effect of abdominal binders on patient's wellbeing after cesarean delivery 12 hours and one week after cesarean section

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Effect of Abdominal Binders on Patient ( Pain, Quality of Recovery ) After Cesaean Section

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

study group (abdominal binders) and control group
Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators
participant and investigator both are masked

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

study group Study group(Group1)

25 participant will be in study group (abdominal binders)

Group Type ACTIVE_COMPARATOR

abdominal binder

Intervention Type DEVICE

study group will be abdominal binders and control group will be control group , 12 hrs and one week later VAS and QOR 40 will assess patient,s wellbeing

Control group (Group 2)

25 participants will be in control group

Group Type PLACEBO_COMPARATOR

abdominal binder

Intervention Type DEVICE

study group will be abdominal binders and control group will be control group , 12 hrs and one week later VAS and QOR 40 will assess patient,s wellbeing

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

abdominal binder

study group will be abdominal binders and control group will be control group , 12 hrs and one week later VAS and QOR 40 will assess patient,s wellbeing

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

any female post cesarean section of singleton 34 wks gestaion fetus with previous cs

Exclusion Criteria

primary cs any hypertensive disorder with pregnancy any neurologiacal disease general anasthesia or vertical incision
Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sohag University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Esraa Saad Abdellattif

Sohag - El Maragha city

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Sohag university Hospital

Sohag, , Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

esraa s abd ellatif, resident

Role: CONTACT

01157145274

abdou s aitallah, professor

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

magdy m amin, professor

Role: primary

References

Explore related publications, articles, or registry entries linked to this study.

Ghana S, Hakimi S, Mirghafourvand M, Abbasalizadeh F, Behnampour N. Randomized controlled trial of abdominal binders for postoperative pain, distress, and blood loss after cesarean delivery. Int J Gynaecol Obstet. 2017 Jun;137(3):271-276. doi: 10.1002/ijgo.12134. Epub 2017 Mar 28.

Reference Type BACKGROUND
PMID: 28241386 (View on PubMed)

Gustafson JL, Dong F, Duong J, Kuhlmann ZC. Elastic Abdominal Binders Reduce Cesarean Pain Postoperatively: A Randomized Controlled Pilot Trial. Kans J Med. 2018 May 18;11(2):1-19. eCollection 2018 May.

Reference Type BACKGROUND
PMID: 29796155 (View on PubMed)

Karaca I, Ozturk M, Alay I, Ince O, Karaca SY, Erdogan VS, Ekin M. Influence of Abdominal Binder Usage after Cesarean Delivery on Postoperative Mobilization, Pain and Distress: A Randomized Controlled Trial. Eurasian J Med. 2019 Oct;51(3):214-218. doi: 10.5152/eurasianjmed.2019.18457.

Reference Type BACKGROUND
PMID: 31692751 (View on PubMed)

Saeed S, Rage KA, Memon AS, Kazi S, Samo KA, Shahid S, Ali A. Use of Abdominal Binders after a Major Abdominal Surgery: A Randomized Controlled Trial. Cureus. 2019 Oct 3;11(10):e5832. doi: 10.7759/cureus.5832.

Reference Type BACKGROUND
PMID: 31754567 (View on PubMed)

Terkawi AS, Tsang S, Abolkhair A, Alsharif M, Alswiti M, Alsadoun A, AlZoraigi US, Aldhahri SF, Al-Zhahrani T, Altirkawi KA. Development and validation of Arabic version of the Short-Form McGill Pain Questionnaire. Saudi J Anaesth. 2017 May;11(Suppl 1):S2-S10. doi: 10.4103/sja.SJA_42_17.

Reference Type BACKGROUND
PMID: 28615999 (View on PubMed)

Terkawi AS, Myles PS, Riad W, Nassar SN, Mahmoud M, AlKahtani GJ, Sala FJ, Abdulrahman A, Doais KS, Terkawi RS, Tsang S. Development and validation of Arabic version of the postoperative quality of recovery-40 questionnaire. Saudi J Anaesth. 2017 May;11(Suppl 1):S40-S52. doi: 10.4103/sja.SJA_77_17.

Reference Type BACKGROUND
PMID: 28616003 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Soh-Med-24-07-20MS

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Sharp Versus Blunt Uterine Incision Expansion
NCT03377894 UNKNOWN PHASE2/PHASE3